Study Summary
This trial will compare the Silq ClearTract™ 100% Silicone 2-Way Foley Catheter to other commercially available urinary catheters to see which one reduces biofilm formation better in subjects that require a long-term indwelling Foley catheter.
- Biofilm Formation
- Urinary Tract Infection
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 0 Secondary · Reporting Duration: 5 to 7 days
Trial Safety
Safety Progress
Trial Design
6 Treatment Groups
Silq Cleartract™ 100% Silicone 2-Way Foley Catheter
1 of 6
Infection Control (I.C.) Latex 2-Way Foley Catheter
1 of 6
Hydrophilix HDX 100% Silicone 2-Way Foley Catheter
1 of 6
Silq ClearTract™ 100% Silicone 2-Way Foley Catheter
1 of 6
Silicone-coated Latex 2-Way Foley catheter
1 of 6
Silver-coated Latex 2-Way Foley Catheter
1 of 6
Active Control
246 Total Participants · 6 Treatment Groups
Primary Treatment: Silq Cleartract™ 100% Silicone 2-Way Foley Catheter · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 4 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| California | 100.0% |
What site did they apply to?
| West Los Angeles VA Medical Center | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Frequently Asked Questions
What is the current head count of individuals involved in this experiment?
"Affirmative. Clinicaltrials.gov data suggests that this medical trial, first posted on December 28th 2021 and updated most recently November 19th 2022, is currently admitting patients. A total of 246 participants are required from 6 different sites." - Anonymous Online Contributor
Are there any vacancies still available for participants of this trial?
"Per the data available on clinicaltrials.gov, this research study is actively recruiting patients. This project was first publicised on December 28th 2021 and its information has been most recently revised as of November 19th 2022." - Anonymous Online Contributor
How many research facilities are partaking in this experiment?
"Currently, enrolment is being accepted from 6 different sites located in West Des Moines, Downey and Tucson as well as other nearby locations. Patients seeking to participate should select the closest location in order to mitigate any additional travel requirements." - Anonymous Online Contributor